Roubaix Capital LLC bought a new position in shares of Neogen Corporation (NASDAQ:NEOG – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 498,424 shares of the company’s stock, valued at approximately $4,630,000. Neogen makes up 2.2% of Roubaix Capital LLC’s portfolio, making the stock its 24th largest position. Roubaix Capital LLC owned about 0.23% of Neogen as of its most recent filing with the SEC.
A number of other institutional investors have also added to or reduced their stakes in the business. UMB Bank n.a. lifted its position in shares of Neogen by 238.2% in the 4th quarter. UMB Bank n.a. now owns 6,422 shares of the company’s stock worth $45,000 after purchasing an additional 4,523 shares during the period. Hantz Financial Services Inc. increased its holdings in Neogen by 816.9% during the fourth quarter. Hantz Financial Services Inc. now owns 7,592 shares of the company’s stock valued at $53,000 after buying an additional 6,764 shares during the period. Cresset Asset Management LLC purchased a new position in Neogen during the second quarter valued at approximately $53,000. Evergreen Capital Management LLC bought a new position in Neogen in the second quarter worth approximately $56,000. Finally, Northwestern Mutual Wealth Management Co. raised its stake in Neogen by 3,158.4% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 8,309 shares of the company’s stock worth $58,000 after buying an additional 8,054 shares in the last quarter. Hedge funds and other institutional investors own 96.73% of the company’s stock.
Neogen Stock Down 0.6%
Shares of Neogen stock opened at $10.27 on Friday. The company has a quick ratio of 2.84, a current ratio of 3.92 and a debt-to-equity ratio of 0.38. The company has a market cap of $2.24 billion, a P/E ratio of -3.67, a PEG ratio of 4.60 and a beta of 1.80. The firm’s 50 day moving average price is $9.15 and its 200-day moving average price is $9.46. Neogen Corporation has a 52-week low of $4.56 and a 52-week high of $11.43.
Analysts Set New Price Targets
Neogen Company Profile
Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.
In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.
Recommended Stories
- Five stocks we like better than Neogen
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.
